Hi there,

This week Democracy Now! is bringing you live, on-the-ground coverage of the Republican National Convention in Milwaukee, where you’ll hear the voices and analysis you won’t get anywhere else. In August, we’ll travel to Chicago for the Democratic National Convention. Democracy Now! doesn’t accept corporate advertising or sponsorship revenue, and we don’t take money from any government. That means we’re relying on you. Can you donate $15 to Democracy Now! to support our RNC and DNC coverage—and so much more? Right now, a generous donor will DOUBLE your gift, which means your $15 donation is worth $30 today. Please do your part to help us air in-depth, substantive coverage of the conventions and the issues that matter most during the 2024 election cycle. Thank you so much—and remember, every dollar makes a difference.
-Amy Goodman

Non-commercial news needs your support.

We rely on contributions from you, our viewers and listeners to do our work. If you visit us daily or weekly or even just once a month, now is a great time to make your monthly contribution.

Please do your part today.


AIDS Activists Welcome Cost Cuts for HIV Drugs in Africa, Though Effective Treatment Remains Out of Reach

HeadlineMar 16, 2001

AIDS activists and workers across Africa yesterday welcomed the sudden wave of cost cuts in HIV drugs for Africa but said that even at drug companies’ newly promised prices, at or below cost for some key drugs, effective treatment against AIDS will remain far out of reach for Africans hardest hit by it. Bristol Myers Squibb announced on Wednesday it will sell two AIDS medications below cost to countries in Africa. The announcement came on the heels of similar deals by leading pharmaceutical companies, including Merck & Co. But AIDS workers said that AIDS drugs have to be used in a cocktail, and some drugs are now cheaper, but some remain unaffordable. Furthermore, the limited number of drugs being offered at reduced cost would leave Africa’s health workers with a reduced packet of ammunition against AIDS, which risks development of more drug-resistant versions of the virus that could worsen Africa’s AIDS problem. However, AIDS activists pointed to another announcement by Bristol Myers as a true breakthrough: the company’s statement that it would waive its patent rights for one of its AIDS drugs in South Africa.

The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to democracynow.org. Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

Non-commercial news needs your support

We rely on contributions from our viewers and listeners to do our work.
Please do your part today.
Make a donation